Market activity suggests a broadening of investor focus as BioProtocol ( BIO ) attracts attention within the emerging decentralized science category. This shift complements the established market position of Aave ( AAVE ) which remains a cornerstone of decentralized liquidity and credit markets. Furthermore the technological advancements seen in Aster ( ASTER ) provide necessary infrastructure for scalable application growth. Together these projects highlight the ongoing evolution of protocol utility and network adoption in the current cycle.